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Abstract
Background: Staphylococcal enterotoxin B (SEB) is a potent immunomodulator and implicated
with pathogenesis of inflammatory diseases mediated by Th1 or Th2 dominant immune responses.
The objective of this study is to determine a possible association between rhinosinusitis derived
SEB and pathogenesis of food allergy (FA).
Methods: The study included chronic rhinosinusitis (CRS) patients with FA (N = 46) or without
FA (N = 33). Controls included FA patients without CRS (N = 26) and healthy volunteers (N = 25).
In CRS patients, we assessed the parameters associated with FA including prick skin test (PST)
reactivity to food allergens, serum levels of allergen-specific IgE and cytokines (IL-4, IL-13, IFN-Î3),
and the number/reactivity of food-allergen specific Th1/Th2 cells in the peripheral blood before and
2 months after sinus surgery. Changes of these parameters were evaluated in comparison with
changes in SEB concentration in the sinus lavage and stool samples and also in vitro reactivity to
SEB. In CRS patients with FA, we also assessed changes in reactivity to oral challenge of offending
food before and after sinus surgery.
Results: Two months following sinus surgery, we observed statistically significant reduction in PST
and oral challenge reactivity in CRS patients with FA in parallel to decrease in serum levels of Th2
cytokines (IL-4 and IL-13) and allergen specific IgE. Improvement of reactivity to food allergens was
positively associated with decline in SEB concentrations in the sinus lavage and stool samples. In
vitro study results also indicated a role of SEB in aggravation of Th2 skewed responses to food
allergens. Such changes were not observed in CRS-non FA patients or control FA patients.
Conclusion: The rhinosinusitis derived SEB plays a certain role in the pathogenesis of FA by
augmenting and/or maintaining polarized Th2 responses. Removal of SEB-producing pathogens
from the rhinosinuses may be beneficial for attenuating the FA symptoms in patients with CRS-FA.
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Background
About 1–2% adults [1] and 4–6% children [2] suffer from
IgE mediated food allergy (FA). The clinical symptoms of
FA vary from slight abdominal discomfort to life-threaten-
ing anaphylactic shock. Avoidance of offending food is
the only effective therapeutic measure currently. FA are
prevalent irrespective with sex, ethnicity, age, and social/
economic class and imposes a heavy burden on health
care expenditure and global economy [3].
Although etiology of FA is still not well understood, sig-
nificant progress has been made for the recent few years
with regard to molecular mechanisms of FA [4]. IgE medi-
ated food allergy is believed to be mediated by type 2 T
helper (Th2) cell responses to food allergens. Th2
cytokines, such as IL-4 and IL-13, promote food allergen-
specific IgE production. IgE-dependent mast cell activa-
tion is regarded as the basis of clinical symptoms of food
allergy [5]. However, the initial steps of antigen specific
IgE over production in the intestine remain to be eluci-
dated. Specific T cell clones to specific antigens are gener-
ated during sensitization. It is unclear what factors dictate
naïve T helper cells to differentiate to antigen specific Th2
cells; how antigen specific immune memory cells live for
a long time and keep bioactivity in the body. It has been
proposed that multiple factors are involved in the devel-
opment and severity of food allergy including genetic,
environmental and immunological factors [6], but the
contributions of these factors to FA pathogenesis remain
poorly understood.
Staphylococcus aureus-derived enterotoxin B (SEB) is one
of the superantigens that possess potent stimulatory activ-
ity on T lymphocytes [7,8]. Antigen-independent, poly-
clonal T cell activation by SEB can worsen inflammatory
condition in both Th1 mediated and Th2 mediated dis-
eases including chronic rhinosinusitis. Thus controlling
staphylococcal colonization or infection may have thera-
peutic implications in these conditions. It is reported that
prophylactic antibiosis for S. aureus revealed protective
effects in atopic dermatitis. However, a role of superanti-
gens in FA is not well understood [9-11].
In clinical practice, we have noticed that some patients
with both chronic rhinosinusitis (CRS) and FA demon-
strate significantly amelioration of FA after treatment of
CRS that can not be explained with the primary treatment.
Our previous studies in rodents revealed that concurrent
oral administration of SEB and food antigens (by gavage
feeding) induces IgE-mediated reactivity to food antigens
in intestinal mucosa [12]. We hypothesized that CRS-
derived microbial products (such as SEB) in nasal dis-
charges could be swallowed down the gastrointestinal
tract to disturb the immune homeostasis in the local tis-
sue. If our hypothesis is correct, attenuation of FA symp-
toms is likely to be observed in CRS-FA patients following
sinus surgery secondary to reduction of SEB swallowed to
the GI tract. We thus examined changes in food allergen
reactivity to PST/oral challenge along with other parame-
ters of FA (serum cytokine levels, serum allergen specific
IgE, and allergen specific Th2 cells) following sinus sur-
gery in CRS-FA patients in comparison with SEB concen-
tration in the sinus and stool and SEB reactivity.
Methods
Subjects
This prospective study was carried out at the Institute of
Allergy and Department of Otolaryngology, Shanxi Medi-
cal University. Patients with both CRS and FA were
selected to this study (These patients had had CRS first,
then FA). The study was approved by the medical ethics
committee at Shanxi Medical University. Informed writ-
ten consent was obtained from each patient. The demo-
graphic data of the subjects included in this study were
presented in Table 1.
Diagnosis of food allergy
Case history
The case history of food allergy was provided by the
patients. Symptoms after specific foods ingestion
included a tingling sensation in the mouth, swelling of the
tongue and the throat, difficulty breathing, hives, vomit-
ing, abdominal cramps, diarrhea, drop in blood pressure,
loss of consciousness, etc. Symptoms typically appear
within minutes to two hours after the ingestion of the
food to which he or she is allergic.
Skin prick test
One drop of extract of each fresh food (purchased from
Beijing Xiehe Hospital, Beijing, China) was applied to the
patients' forearm. The skin covered by the drop of food
antigen was pricked with 1 mm single-peak lancets. Posi-
tive control was performed using 10 mg/ml histamine
dihydrochloride; the negative control using saline solu-
tion. The results were read after 15 min. The outline of
each weal was documented using a piece of transparent
paper to copy the wheal [13]. The skin wheal areas were
determined with scanned digital files using the software
ImageJ. Skin prick tests were regarded positive when the
area was larger than 7 mm2. Subjects with a weal area
below 3 mm2 in positive controls were excluded from this
study.
Oral challenge with food antigens
Oral challenges were performed in all the subjects in this
study using one of the food allergens that the study sub-
ject revealed positive prick skin test reactivity (usually
using the one had the largest wheal area). We used 10
common food allergens in the skin prick test to screen the
offending allergens in these patients including cow milk,BMC Gastroenterology 2006, 6:24 http://www.biomedcentral.com/1471-230X/6/24
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hen eggs, wheat, soy, shrimp, peanut, carrot, pork, beef,
and fish although some patients might also sensitize to
other food antigens. Patients being treated with an anti-
histamine or corticosteroids were advised to stop taking it
for 72 h before provocation. The oral challenge was per-
formed in double blind manner. The antigen extracts or
placebos were contained in coded capsules. The patients
took 3 capsules of antigen or placebo; they were asked to
take another 3 capsules (placebo or antigens) one week
later. The study subjects were closely monitored for 4
hours following oral challenge in the facility where treat-
ment of anaphylaxis was readily available. The healthy
controls and CRS patients were also oral challenged with
a mixture of the 10 antigens. The clinical symptoms were
scored as 0 to 5. Score 5 indicated severe; score 0 indicated
no symptom.
Serum levels of cytokine and allergen-specific IgE
Blood samples were collected from each patient before
and two month after the treatment of CRS, and also from
healthy controls and CRS alone patients with two months
apart from each time. The sera were separated immedi-
ately after withdrawn and stored at -70°C until use. The
levels of total IgE, antigen specific IgE, IL-4, IL-13 and IFN-
γ in the sera were measured with ELISA. The reagent kits of
IgE were purchased from Pharmacia (Beijing, China.) The
reagent kits of cytokines were purchased from Genetimes
Tech Inc. (Shanghai, China). The procedures were follow-
ing the manufacturer's instructions. Negative controls
included omitting the primary antibodies and using iso-
type IgG instead of the primary antibodies for each
parameter.
Diagnosis and treatment of CRS
We diagnosed CRS as inflammation of the sinus mucosa
with a persistent mucoid or mucopurulent nasal discharge
for longer than 3 months that resisted antimicrobial ther-
apy and antral irrigation. Diagnosis was made on the basis
of clinical history, rhinoscopic findings, and computed
tomographic scan of rhinosinuses. CRS was confirmed by
computed tomographic examination that showed diffuse
mucosal thickening in the ethmoid or/and maxillary
sinuses bilaterally with scores higher than 12 by the Lund-
Mackay staging system [14]. The procedures of FESS
(functional endoscopic sinus surgery) followed the previ-
ous reports [15]. The surgical side of sinus was irrigated
daily post-FESS until the irrigated fluids became clear.
After discharge, the patients were required to visit the hos-
pital to conduct a post-operation examination of nasal
cavity and sinuses on a monthly basis for the first year.
Any unusual feelings in the operated sinus area were
recorded. Physicians would do necessary treatment for
relapse of inflammation in the sinuses during the entire
follow-up period.
The CRS in the patients selected in this study had been
treated with many means and got poor results. They thus
pleaded to FESS following physician's advice. All the CRS
patients (including CRS-FA and CRS alone) underwent
FESS in their maxillary sinusitis. Among the CRS-FA
patients, 8 (17.4%) patients also underwent bilateral eth-
moidectomy. 9 patients also underwent unilateral eth-
moidectory (19.6%, right or left side). 6 (13%) patients
also underwent septum orthomorphia. 18 (39.1%)
patients had nasal polyps that were removed during FESS.
3 (6.5%) patients underwent partial middle turbinec-
tomy. 6 (13%) patients underwent inferior turbinectomy.
During the 2 month observation period, all the patients
underwent regular follow-up visit (The total follow-up
period lasted for one year after FESS). 2 months after FESS,
all the patients reported significant improvement in their
clinical symptoms of CRS. Clinical symptom scores were
Table 1: Demographics of the study subjects
Groups CRS FA CRS-FA Healthy
S e x F e m a l e 1 71 3 2 61 2
male 16 13 20 13
Age Range 22~43 17~46 16~55 20~22
Average 24.6 ± 5.2 28.6 ± 3.9 25.8 ± 4.8 20.3 ± 0.3
FA history (years) Range No 0.8~11 0.5~11 No
Average No 3.1 ± 2.6 3.3 ± 2.1 No
CRS history Range 2.5~11 No 2.2~18 No
Average 6.3 ± 2.4 No 5.4 ± 1.7 No
Other allergy No No 8 with AD No
Previous FESS No No No No
Polyposis 8 0 18 0
hyperplastic sinusitis 6 0 12 0
Serum total IgE (pg/ml) 76.9 ± 21.8 699.3 ± 85.2* 765.2 ± 94.3* 55.6 ± 15.4
*, p < 0.05, compared with healthy group. FA: food allergy. CRS: chronic rhinosinusitis. AD: atopic dermatitis. FESS: functional endoscopic sinus 
surgery.BMC Gastroenterology 2006, 6:24 http://www.biomedcentral.com/1471-230X/6/24
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recorded before and 2 months after FESS that were
defined from 0 to 4 (0 for no symptoms; 4 for severe).
Most patients had moderate to severe CRS clinical symp-
toms before FESS; 40 out of 46 (87%, scored 0 and 1)
patients showed significant attenuation in their clinical
symptom of sinusitis.
Measurement of SEB in sinus (or nasal) wash fluids (SWF) 
and stools
Every patient with CRS underwent maxillary sinus punc-
turing and irrigating with saline. The SWF was collected
prior to other procedures. Five ml saline was injected into
the sinus cavity and recollected and stored at -70°C for
further analyses. For the ethic reason, nasal lavage fluids
(5 ml saline) instead of sinus irrigation were collected
from the healthy controls and FA controls. None of the
subjects had acute upper respiratory acute infections
within the past month. Stool samples were also collected.
100 mg stool samples were dissolved in 0.5 ml PBS, mixed
well, stayed at 4°C for 20 min, centrifuged for 10 min at
17,000 × g at 4°C. The supernatants were collected and
subjected to the evaluation of SEB, SEA and TSST1 (toxic
shock syndrome toxin 1). Contents of SEB, SEA and TSST1
in SWF were evaluated with ELISA following reagent man-
ufacturer's instructions.
Identification of S. aureus in sinuses
Surgically removed sinus tissues were obtained from each
patient (a nasal lateral wall swab was obtained from FA
alone patients and healthy controls instead) and were sent
to the Microbiological Laboratory within 30 minutes. 100
mg mucosa was homogenized in 0.1 ml saline. The same
volume of the homogenates from each patient was cul-
tured aerobically on blood agar plates. Colonies of differ-
ent morphology growing on the agar were separately
enumerated, subcultured on blood agar, Gram stained,
and tested for catalase production. Isolates with a typical
Gram-stained appearance and a positive catalase test were
tested for coagulase production, and positive isolates were
regarded as S. aureus. The template DNA was extracted
from the positive cultured colony of each subject with the
procedures reported by Riffon [16]. PCR was performed
with the samples from each subject. The primers of SEB
were referred to the previous report [17]: 5'-ttgcatatccgcgt-
caaata-3' and 5'-cttcatgttctttcgcatcg-3'. Amplification was
performed on a Perkin-Elmer (Norwalk, Conn.) thermo-
cycler in 25-μl reaction mixtures. The program consisted
of an initial denaturation step at 94°C for 2 min, followed
by 22 cycles of 1 s at 94°C, 2 s at 58°C, and 10 s at 72°C,
with a final extension step at 72°C for 5 min. Amplifica-
tion products were separated on a 1% agarose gel and
stained with ethidium bromide before being analyzed on
a UV bench by using GelDoc2000 (Bio-Rad). The PCR
products were routinely sequenced to confirm amplifica-
tion of the targeted sequence.
Antigen specific CD4 T cell proliferation assay
Heparinized blood samples (40 ml) were obtained from
each subject before the sinus surgery. PBMCs were sepa-
rated by gradient density centrifugation. 5 × 105/ml
PBMCs were cultured in vitro in the presence or absence
of a food allergen to which the study subject revealed the
most significant prick skin test reactivity (a mixture of the
10 antigens was used in the culture of PBMCs from the
controls) at a dose of 10 μg/ml for 96 h. A portion of the
cells were cultured with SEB (20 μg/ml) in addition to the
specific antigens. The supernatants were collected at the
end of the culture. The cytokines of Th1 (IFN-γ) and Th2
(IL-4) in the supernatants were determined with ELISA as
described above. Another batch of cells were cultured in
the presence of brefeldin A (10 μg/ml, Sigma) in addition
to the culture conditions above. These cells were fixed
with 1% paraformaldehyde for 1 h at room temperature,
stained with FITC labeled anti-IL-4 antibody (for Th2
cells) and PE labeled anti-IFN-γ antibody (for Th1) for 30
min on ice. The positively stained cells were counted with
flow cytometry.
Another batch of PBMCs from patients with CRS-FA were
cultured in the presence of the specific antigens and SEB
(20 μg/ml) or in the presence of specific antigen (or SEB)
alone. The supernatants were sampled on day 0 and every
3 days. IL-4 levels in the supernatants were measured with
ELISA as described above.
Statistics
Outcome variables were summarized descriptively using
means and standard deviations for continuous variables
and counts and proportions for categorical variables. A
paired T-test for continuous variables and McNemar's Test
for binary variables was used to evaluate the within group
differences (between the first and the second measure-
ments or between the measurements taken before and
after the sinus surgery). Between-group differences in the
clinical and laboratory characteristics in patients with
CRS-FA and healthy control or patients with FA or with
CRS were analyzed using Kruskal-Wallis test or ANOVA as
appropriate. Post-hoc comparisons were performed using
Mann-Whitney U test or Student t test to look for signifi-
cant differences between pairs of subject groups. The cor-
relations between the reduction of individual antigen
induced clinical symptom score after FESS and other
parameters were determined by Spearman rank correla-
tion coefficient respectively. All comparisons were made
two-sided, and p < 0.05 was considered significant.
Results
FESS attenuated reactivity to oral food allergen challenge 
in CRS-FA patients
Each subject underwent two times of skin prick test with
the 10 designated antigens before and two months afterBMC Gastroenterology 2006, 6:24 http://www.biomedcentral.com/1471-230X/6/24
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the sinus surgery. The healthy control group did not show
any positive reactions to the 10 antigens (the wheal area
was less than 7 mm2), nor in the patients with CRS alone.
The wheal area larger than 7 mm2 was observed in the
CRS-FA patients in 2 to 8 antigens that was markedly
decreased in two months after the FESS (Table 2). Two
months following FESS, CRS-FA patients revealed signifi-
cant reduction of FA symptoms provoked by oral chal-
lenge of offending food allergens. There was no change in
reactivity in FA patients in the repeated oral challenge test.
FESS reduced serum levels of Th2 cytokines and allergen
specific IgE in CRS-FA patients (Table 3).
Treatment of CRS attenuated clinical symptoms of FA
As shown in Table 4, both CRS-FA patients and FA
patients showed gastrointestinal symptoms in response to
the food antigen challenge. A mixture of the 10 food anti-
gens using in this study was taken in by the healthy con-
trols and the CRS controls; none of them reported any
gastrointestinal symptoms. The placebo did not evoke any
symptoms in all the subjects. Two months after the FESS,
the oral antigen challenge was repeated. The clinical
symptoms induced by the first oral antigen challenge were
significantly attenuated in patients of CRS-FA group but
not in FA group (Table 4).
Levels of serum Th2 cytokines and specific IgE decreased 
after CRS treatment
Significant reduction of serum levels of Th2 cytokines (Fig
1A, B) and antigen specific IgE (Fig 1D) were observed in
patients with CRS-FA 2 month after the FESS, but no
changes in the serum levels of IFN-γ were observed (Fig
1C). In patients with CRS alone, the Th1 pattern cytokine
levels were attenuated after the FESS (Fig 1C), but their
serum Th2 cytokines did not change significantly (Fig 1A,
B), nor did the specific IgE levels (Fig 1D). We did not
notice much change in the serum cytokine and specific IgE
levels in healthy controls between the two tests (Fig 1A–
D).
SEB was identified in the sinus lavage and stool samples in 
CRS-FA patients at high concentration
The levels of SEB, but not SEA and TSST-1 were detected
in sinus wash fluids and in the stools that were signifi-
cantly higher in patients with CRS-FA as compared to
patients with CRS alone or to healthy controls (Fig 2A and
2B). Bacterial culture resulted in the S. aureus growth in
surgically removed sinus tissue in 41 out of the 46 patients
(89.1%) with CRS-FA. The numbers of S. aureus colonies
in the culture ranged from 0 to 96 with an average of 27.8/
patient. Much less number of S. aureus was detected in
surgical removed sinus tissues of patients with CRS only
(63.63%) ranged from 0 to 20 colonies per patient (Fig
2C). PCR results showed the S. aureus DNA amplified
products from surgical removed tissue of 46 (100%)
patients that further confirmed the existence of S. aureus
infection in the sinuses of patients with CRS-FA (Fig 2D).
PCR amplified product sequence analysis confirmed that
the amplified bands were in consistent with the target
DNA sequences.
Food allergen-specific Th2 responses are augmented by 
SEB in vitro in CRS-FA patients but not in FA patients
When cultured with food allergens or SEB, PBMCs from
CRS-FA patients produced higher levels of IL-4 (Fig. 3-A,
Table 5) than cells cultured without stimuli. PBMCs stim-
ulated with food allergen plus SEB revealed the highest IL-
4 production. PBMCs from FA patients also increased the
IL-4 production in response to stimulation of food aller-
gens. Food allergen-specific Th2 responses are augmented
by SEB in vitro in CRS-FA patients but not in FA patients.
In order to determine if SEB has any effect in maintaining
the immune activity of antigen specific Th2 cells in CRS-
FA patients, separated PBMCs were cultured with specific
antigens in the presence or absence of SEB or SEB alone.
In consistent with previous reports [18,21], we observed
the rapid increases in IL-4 production in samples from
patients with CRS-FA. However, the IL-4 production
declined rapidly afterwards in PBMCs exposed to antigen
alone or SEB alone. The IL-4 production kept at high lev-
els through the observed period in the PBMCs exposed to
both specific antigens and SEB concurrently (Fig 4).
The correlations between reductions of individual antigen
induced clinical symptom score after FESS and other 12
parameters collected before FESS were determined by
Spearman rank correlation coefficient respectively. As
shown in Table 6, FESS, SEB and S. aureus were signifi-
cantly correlated with the reduction of antigen induced
clinical symptom scores.
Table 2: Wheal area (mean ± SD, mm2) of skin prick test
Healthy CRS CRS-FA FA
1st 2.1 ± 1.2 5.5 ± 1.8 89.8 ± 14.5 75.3 ± 8.9
2nd 2.2 ± 1.2 4.2 ± 1.2 23.6 ± 5.6* 81.2 ± 12.2
1st: the first skin prick test; 2nd: the second skin prick test.
*, p < 0.05, compared with the results of the first skin prick test within the same group.BMC Gastroenterology 2006, 6:24 http://www.biomedcentral.com/1471-230X/6/24
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Discussion
Rhinosinusitis is one of the most common health care
complaints in both industrial [19] [48] and developing
countries [20] [49]. S. aureus is a common pathogen that
contributes to both acute and chronic rhinosinusitis [21]
[50]. The cumulative evidence indicates that SEB is
involved in the pathogenesis of allergic diseases [22] [51].
The coincidence of CRS and food allergy has been noticed
by us from late of 1980s as well as by others [23,24] [52,
53]. The results of our study revealed evidence of a role of
SEB produced as a result of CRS for development and/or
aggravation of Th2 responses to food allergens in the gut
mucosa.
The sinus surgery has resulted in an attenuation of Th2
skewed responses to food allergens in CRS-FA patients,
most likely secondary to removal the source of SEB.
Because of opening to natural environment, the sinuses
are easily to become contaminated and colonization by S.
aureus. Clinical evidence has indicated that S. aureus is a
common pathogen in acute and chronic rhinosinusitis
[25,22]. The rhinosinusitis secretions (some contain SEB)
are naturally discharged to the nasal cavity and compelled
backward by the ciliated nasal mucosa, sometimes to be
swallowed down the gastrointestinal tract. This postula-
tion is supported by the present results. The results
showed that S. aureus colonization in the sinus mucosa
was more than 90% patients with CRS-FA; high levels of
SEB in the sinus wash fluids and in the stools were
detected. Others also have identified S. aureus in human
intestine [26-28,23-25]. SEB is an immune active mole-
cule that can affect the intestinal immune homeostasis.
Previous studies indicate that SEB can bind, without
processing by antigen processing cells, to an outside
domain of major histocompatibility class II molecules
and the variable portion of the β-chain of the T-cell recep-
tor on specific subsets of T cells, and so can activate up to
25% of all T cells [29,26]. In another word, SEB can
induce polyclonal T cell activation, leading to aberrant
immune responses. Our recent study shows that SEB com-
promises intestinal epithelial barrier function and
increases intact protein antigen absorption [30,20]. These
intact antigens thus have the opportunity to contact the
immune cells in the intestinal mucosa and further com-
promise the intestinal immune homeostasis. The present
data are in consistent with our previous studies which
demonstrate that SEB acts as an adjuvant in inducing
intestinal sensitization in a murine model [30,20] and is
associated with ulcerative colitis [17].
Antigen skin test is an initial approach in diagnosing FA.
Previous reports have mentioned a positive correlation
between IL-4 positive mast cells and the wheal size
[31,27]; antigen specific IgE levels and cutaneous allergic
reactions [32,28]. The attenuation of wheal size of skin
Th2 cytokines and IgE levels were decreased in the sera of  patients with CRS-FA after the sinus surgery Figure 1
Th2 cytokines and IgE levels were decreased in the sera of 
patients with CRS-FA after the sinus surgery. Th1/Th2 
cytokines and specific IgE were measured with ELISA as 
detailed in the text. Bars represent levels of cytokines or IgE 
in the sera. Data are expressed as mean ± SD. *, p < 0.05, 
compared with values of the 1st tests (before surgery).BMC Gastroenterology 2006, 6:24 http://www.biomedcentral.com/1471-230X/6/24
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prick tests implicates that less number of IgE molecules
has been produced and bound to mast cell surface. FESS
appeared to have significantly attenuated prick skin test
reactivity to food allergens.
Inhibition of FA clinical symptoms is the summit aim of
FA research and clinical practice. The present study docu-
mented a significant amelioration of FA clinical symp-
toms from specific antigen challenge in CRS-FA patients
after the sinus surgery. In line with previous reports
[33,34,30,31], the results also showed the high levels of
serum Th2 cytokines and antigen specific IgE in the FA
patients in this study. The improvement occurred in the
CRS-FA patients after the sinus surgery, but not in the FA
alone patients, implicates that the sinus surgery has
resulted in immune regulatory effect, possibly attributing
to the removal of pathogen from the sinuses.
Table 3: Positive antigen number (mean ± SD) of skin prick test
Skin Test CRS-FA FA
1st 7.3 ± 1.1 6.8 ± 0.6
2nd 3.2 ± 0.8* 6.7 ± 0.5
1st: the first skin prick test; 2nd: the second skin prick test.
*, p < 0.05, compared with the results of the first skin prick test 
within the same group.
SEB was detected in the sinuses and in the stools of CRS-FA patients Figure 2
SEB was detected in the sinuses and in the stools of CRS-FA patients. Bars represent SEB levels in the sinus (or nasal) wash flu-
ids (A) or in the stools (B) that were detected with ELISA. Data are expressed as mean ± SD. *, p < 0.05, compared with values 
of the 1st tests (before the sinus surgery; 2nd: 2 months after the sinus surgery). #, p < 0.05, compared with healthy controls. $, 
p < 0.05, compared with CRS patients. C, S. aureus was identified with the surgical sinus samples after bacterial culture. D, S. 
aureus DNA was identified with PCR. Band 1 is the negative control; bands 2 and 3 are the representative bands of samples 
from patients with CRS-FA.BMC Gastroenterology 2006, 6:24 http://www.biomedcentral.com/1471-230X/6/24
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As reported before, we also examined S. aureus infection
in the sinuses of these CRS-FA patients. As expected, more
than 90% patients had S. aureus colonization in their
sinuses. The removal of S. aureus infection from the
sinuses positively correlates with the attenuation of FA
clinical symptom. This event revealed a possible associa-
tion between the S. aureus infection in the sinuses and the
pathogenesis of FA. SEB has high immune activity in acti-
vating T cells and induces aberrant immune reactions. It is
true that most reports on the topic of SEB discuss its effect
on Th1 pattern reaction [35,36,32,33]. Yet the cumulative
evidence demonstrates that SEB is also involved in the dis-
orders of Th2 reactions such as allergic dermatitis [37,34],
allergic rhinitis, asthma [38,35], etc as observed clinically.
Many investigators observe the effect of SEB alone on
immune function. In reality, in most situations, mole-
cules act with one another concurrently or synergistically
in the body. When animals were exposed to SEB and food
antigen ovalbumin concurrently as we reported previ-
ously [17], intestinal sensitization was induced whereas
those animals exposed to SEB or ovalbumin alone did not
show any signs of intestinal sensitization, implicating that
SEB may act as an adjuvant in the induction of intestinal
sensitization with food antigens. SEB can cause polyclonal
T cell activation and depending on the pre-existing
inflammatory condition, either Th1- or Th2- mediated
inflammatory condition can be aggravated.
In general, the re-expose of atopic patients to specific aller-
gens provokes a Th-2 response, with increases in the pro-
duction of IL-4 and IL-13. These cytokines facilitate IgE
production. The CRS-FA patients in this study showed an
aberrant Th2 pattern immune reaction as high levels of
serum antigen specific IgE, IL-4, IL-13 and low levels of
IFN-γ were recorded before the treatment of their sinus
disorders (Fig 3). This is in consistent with the concept
that food allergy belongs to Th2 immune disorder
[30,33]. The attenuation of Th2 cytokines and IgE anti-
body after the sinus surgery in these patients would sug-
gest an improvement of the aberrant Th2 polarization;
although the precise mechanism needs to be further eluci-
dated, the results demonstrate a possibility that this
improvement can be associated with reduction of S. aurus
colonization after FESS.
One of the approaches we took in this study is the expo-
sure of separated PBMCs to specific antigens and SEB. A
rapid increase in the IL-4 production as well as the antigen
specific Th2 cell proliferation was observed in vitro. The
phenomenon is well documented in the skewed Th2
polarization disorders such as FA [39,38] and asthma
[40,39]. Our results support the notion that the antigen
Peripheral blood mononuclear cells (PBMCs) were got from  all subjects and cultured in the presence of specific antigens Figure 3
Peripheral blood mononuclear cells (PBMCs) were got from 
all subjects and cultured in the presence of specific antigens. 
Supernatants were collected on day 4 and subjected to the 
assessment of IL-4 (A) and IFN-γ (B) with ELISA. Blank: no 
special treatment. Ag: treated with specific antigens. SEB: 
treated with SEB; SEB+Ag: treated with the combination of 
SEB and Ag. Data are presented as mean ± SD. *, p < 0.05, 
compared with blank group; #, p < 0.05, compared with the 
groups treated with Ag alone or with SEB alone.
Table 4: Clinical symptom scores (mean ± SD) evoked by oral antigen challenge
Patients Challenge Nausea Vomiting Diarrhea Gut cramp
CRS-FA 1st 4.1 ± 0.6 2.3 ± 0.3 1.9 ± 0.2 2.9 ± 0.4
2nd 1.1 ± 0.3* 1.1 ± 0.3* 0.6 ± 0.2* 0.8 ± 0.3*
FA 1st 4.2 ± 0.7 2.3 ± 0.5 1.6 ± 0.4 2.8 ± 0.4
2nd 4.3 ± 0.8 2.4 ± 0.8 1.5 ± 0.5 2.5 ± 0.5
1st: the first oral antigen challenge; 2nd: the second oral antigen challenge.
*, p < 0.05, compared with the results of the first skin prick test within the same group.BMC Gastroenterology 2006, 6:24 http://www.biomedcentral.com/1471-230X/6/24
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specific Th2 cells exist in the peripheral blood stream of
the patients with FA. These cells are capable of rapid pro-
liferating to effector cells in response to stimulation of
specific antigens. The addition of SEB to the culture fur-
ther increased Th2 responses in the PBMCs from patients
with CRS-FA, but not from those with either CRS or FA
alone. The presented data indicate that SEB may further
augment responses of food allergen specific Th2 cells
directly or by bystander effect. This point might be the
basis that SEB and specific antigens can act synergistically
on the immune memory T cells to augment their func-
tions. Similar results have been reported in patients with
allergic rhinitis and nasal carriage of S. aureus [41,40]. SEB
has the property to modulate the T cell immunity via
inducing polyclonal T cell expansion, or deletion or
anergy depending on certain environment [42,41]. The
CRS-FA patients might have genetic predisposition to
respond rigorously to SEB and by bystander effect, their
Th2 responses to food allergens may be further aug-
mented as one possible explanation. There may be other
possibilities as well. After the removal of SEB source, the
pathogen from the sinuses, the FA signs, including the
wheal area in skin prick tests and the clinical symptoms
evoked by exposure to specific food antigens are signifi-
cantly attenuated. The data from cell culture show that
SEB is required in maintaining the immune activity of
antigen-specific Th2 cells from CRS-FA patients further
supporting the clinical findings. It is likely the FA status in
these patients relies on the existence of SEB, at least par-
tially.
Conclusion
In summary our study revealed significant improvement
of reactivity to food allergens by PST and oral challenge in
CRS-FA patients after FESS. Improved FA symptoms are
paralleled with evidence of attenuated Th2 responses to
food allergens and decrease of SEB concentrations in the
sinus and the gut. Along with in vitro study results indicat-
ing augmenting action of SEB on food allergen specific
Table 6: Univariate analysis on reduced antigen induced clinical 
symptom score as a dependent variable
Independent variable r p
Ag -0.061 NS
Sex 0.052 NS
Case history (CRS) 0.101 NS
Case history (FA) 0.118 NS
S. aureus colonies 0.696 <0.01
SEB (sinus) 0.659 <0.01
SEB (stool) 0.797 <0.01
FESS 0.889 <0.01
Wheal area of skin prick test 0.029 NS
Serum specific IgE 0.036 NS
Serum IL-4 0.057 NS
Serum IL-13 0.048 NS
Serum IFN-gamma -0.059 NS
Table 5: Frequency of IL-4+ or IFN-γ+ T cells following stimulation with SBE, food allergen, or both (%, assessed by flow cytometry)
Treatment Th1 or Th2 Healthy CRS CRS-FA FA
Blank Th1 23.3 ± 5.4 34.3 ± 4.2 11.4 ± 4.4 13.4 ± 2.5
Th2 25.3 ± 3.4 18.6 ± 2.5 35.3 ± 3.3 35.6 ± 2.6
SEB Th1 20.8 ± 3.6 30.8 ± 4.3 10.3 ± 2.1 10.7 ± 0.6
Th2 22.3 ± 4.1 15.3 ± 2.2 45.8 ± 5.2* 12.5 ± 1.3*
Ag Th1 20.2 ± 4.2 35.2 ± 3.2 10.2 ± 1.6 10.2 ± 1.1
Th2 26.3 ± 6.4 16.6 ± 3.3 46.9 ± 2.8* 36.7 ± 3.3
SEB + Ag Th1 20.7 ± 3.6 33.8 ± 2.5 5.8 ± 0.3* 10.6 ± 0.5
Th2 21.9 ± 5.1 15.6 ± 4.5 81.9 ± 6.7*# 31.2 ± 2.9
Data are presented as mean ± SD. *, p < 0.05, compared with the blank cells. #, p < 0.05, compared with the cells treated with SEB or Ag alone. 
Comparison was done between treatments within the same group. IL-4 was detected to present Th2 profile and IFN-γ was detected to present 
Th1 profile.
Separated PBMCs from patients with CRS-FA before FESS  were cultured in the presence of specific antigens and SEB or  antigen (or SEB) alone Figure 4
Separated PBMCs from patients with CRS-FA before FESS 
were cultured in the presence of specific antigens and SEB or 
antigen (or SEB) alone. Supernatants were sampled every 
three days and subjected to IL-4 analysis. Bars represent IL-4 
levels in the supernatants (mean ± SD). *, p < 0.05, compared 
with IL-4 levels at day 0 within the same group.BMC Gastroenterology 2006, 6:24 http://www.biomedcentral.com/1471-230X/6/24
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Th2 responses in CRS-FA patients, the presented data sup-
port a role of SEB in development/aggravation of FA in
some CRS patients.
Abbreviations
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